MedTrace Logo

Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome

NCT02774707 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-12-08

No results posted yet for this study

Summary

Human autologous serum is commonly used in the treatment of dry eye disease. However, different patients may have different effect with autologous serum treatment. We would like to find if different autologous serum had different component of cytokines in different etiologies of dry eye.

Conditions

  • Dry Eye Syndrome

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Wei-Li Chen · ational Taiwan University Hospital, Ophthalmology Department

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02774707 on ClinicalTrials.gov